Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi

Showing 15 posts of 579 posts found.

Study supports GLP-1 agonists for weight loss

January 10, 2012
Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Sanofi, diabetes, lilly

An independent study by academics has concluded that GLP-1 agonist drugs help patients to lose weight – with the effect …

News
Sanofi picture

Sanofi sheds dermatology unit for $423 million

December 19, 2011
Manufacturing and Production, Sales and Marketing Canada, Dermik, Sanofi

Sanofi has completed the sale of its Canadian-based dermatology business Dermik for $422.5 million.  The unit has been sold to …

News

No cancer link with Lantus, says Sanofi

December 7, 2011
Sales and Marketing Cancer, Lantus, Sanofi, diabetes, insulin, safety

Sanofi has presented a new meta-analysis which suggests its insulin blockbuster Lantus does not raise the risk of cancer. A …

News
Gardasil picture

UK government drops Cervarix for Gardasil

November 28, 2011
Sales and Marketing Cervarix, GSK, Gardasil, MSD, Sanofi

The UK government has performed a U-turn on its HPV vaccine programme by favouring Sanofi and MSD’s Gardasil over GlaxoSmithKline’s …

News

Multaq raises risk of death in permanent AF patients

November 16, 2011
Sales and Marketing AF, Multaq, Sanofi

More bad news for Sanofi’s Multaq as new data shows the drug doubles the risk of death in people with …

News

Sanofi’s Lemtrada beats Rebif in new study

November 14, 2011
Research and Development, Sales and Marketing Lemtrada, Rebif, Sanofi

Lemtrada has beaten Merck Serono’s multiple sclerosis treatment Rebif in a new head-to-head trial, paving the way for regulatory submission …

News
Sanofi HQ pic

Sanofi to become world’s biggest drug maker

November 2, 2011
Medical Communications, Research and Development, Sales and Marketing Pfizer, Sanofi, top 10

Sanofi will replace Pfizer as the world’s biggest drug maker by revenue next year, according to new forecasts.  Pfizer’s nine-year …

News

David Meeker appointed as chief executive of Genzyme

October 25, 2011
Research and Development, Sales and Marketing Genzyme, Sanofi

Sanofi has appointed David Meeker as chief executive of its new biotech acquisition Genzyme. He will report to Christopher Viehbacher, …

Appointment
Sanofi HQ

Sanofi’s Lemtrada beats Rebif in MS study

October 25, 2011
Research and Development, Sales and Marketing Lemtrada, Sanofi

Sanofi’s investigational multiple sclerosis drug Lemtrada has beaten Rebif in a late-stage trial. The Phase III results show that 78% …

News

Genzyme completes expansion at Waterford plant

October 14, 2011
Manufacturing and Production Genzyme, Sanofi

Sanofi’s Genzyme unit has officially opened a €150 million expansion at its ten-year-old biotechnology facility in Waterford, Ireland that will …

News

Sanofi spots acne vaccine opportunity

September 22, 2011
Research and Development Sanofi, acne, dermatology

Sanofi Pasteur has signed a new research deal with the University of California, San Diego for its investigational acne vaccine. …

News

Sanofi banks on personalised medicine for growth

September 8, 2011
Sales and Marketing Genzyme, Sanofi

Sanofi has nailed its colours to the mast of personalised medicine, banking on the purchase of US biotech company Genzyme, …

News

Sanofi’s Multaq in the dock

September 7, 2011
Sales and Marketing Multaq, Sanofi

The EMA will later this month decide whether Sanofi’s Multaq can remain on the market after reports emerged of serious …

News
Sanofi

Sanofi battles strong headwinds in second quarter

July 29, 2011
Sales and Marketing Sanofi

Sanofi’s acquisition of Genzyme helped its revenue grow in the second quarter, but underlying growth from the French firm disappointed. …

News

Sanofi eyes phase III move for sarilumab in rheumatoid arthritis

July 13, 2011
Research and Development Regeneron, Sanofi, ankylosing spondylitis, research and development news, rheumatoid arthritis, sarilumab

Sanofi is poised to move sarilumab into phase III trials for rheumatoid arthritis after the monoclonal antibody showed positive results …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025